Logo-aim
Original Article

1. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study
Abdorreza Naser Moghadasi* ORCID, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Vahid Shaygannejad, Nassim Anjidani, Fereshteh Ghadiri, Behnaz Sedighi, Morteza Saeidi, Hamed Amirifard, Hormoz Ayromlou, Nahid Beladi Moghadam, Mohammad Bagher Ranjbar, Masoume Nazeri, Zahra Niknam, Fardin Faraji, Afsaneh Afsorde, Mohammad Ali Sahraian ORCID
Arch Iran Med. 2023;26(11): 647-653. doi: 10.34172/aim.2023.95
PMCID: PMC10864943     PMID: 38310425    
Article
PDF
Suppl 1
XML
Cited By:
0
0
0

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.